Analyst initiations: MNOV, RIG and LII
Posted May 15th 2008 11:09AM by Eric Buscemi
Filed under: Analyst reports, Dean Foods (DF), Analyst initiations
.gif)
MOST NOTEWORTHY: MedicNova, Transocean and Lennox were today's noteworthy initiations:
- Rodman & Renshaw is positive on MedicNova's (NASDAQ:MNOV) two primary products in development: MN-221, for the treatment of severe asthma and MN-166, an oral treatment for multiple sclerosis. The firm is also positive on MNOV's valuation; shares were initiated with an Outperform rating and $9 target.
- Transocean (NYSE:RIG) is UBS's Top Pick as they believe it is the primary beneficiary of rising deepwater dayrates. Shares were assumed with a Buy rating and $201 target.
- Suntrust initiated Lennox (NYSE:LII) with a Neutral rating and cites near-term visibility.
OTHER INITIATIONS:
Tags: analyst, dean foods, DeanFoods, df, hercules, hero, initiation, inthenews, lennox, lii, medicnova, mnov, parker-hannafin, pde, ph, pride, rig, transocean
Related Posts
- Start drilling offshore: ATW, DO, ESV, HERO, NE, PDE, RDC, RIG (29 days ago - 1 Comments)
- Analyst initiations: AAPL, PNRA and AMZN (63 days ago - 0 Comments)
- Analyst downgrades: First Solar, Pride International, EnerSys (64 days ago - 0 Comments)
- Merck (MRK) higher on Buy rating despite Vioxx settlement news (6 days ago - 0 Comments)
- Six stocks for a difficult market: Reiterating the Fab Five (plus one) (15 days ago - 0 Comments)
Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.
When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br> tags.
Earnings preview for Ford
Apple shares rise on report Steve Jobs is free of cancer
Toyota whups GM in the first half of 2008
